Upon effectiveness of the Novo Collaboration Agreement, the Company received a one-time, non-refundable upfront payment of $ Under the Novo Collaboration Agreement, the Company has a one-time option to share in the global development costs and operating profits or losses (in lieu of milestones and royalties) with respect to one licensed product (the "Profit Share Option"), subject to certain terms, conditions and limitations
Drug Quality and Security Act (DQSA)
The development of extended-release formulations, such as exenatide ER using microsphere technology, represents a notable advancement in the pharmaceutical field
Change Your Life Today For Only $249/month Preventative Measures to Minimize Chest Pain Risk When taking semaglutide, it is essential to understand how to minimize the risk of chest pain
I will use it for an extra month to reach a reasonable weight and after that will follow a diet and change my lifestyle by going to the gym. Read Full Story: TheNational